AFT Pharmaceuticals announced the licensing of Maxigesic IV, the intravenous form of its proprietary pain relief medicine, for Brazil, the largest pharma market in South America and the tenth largest pharma market in the world. AFT has now out-licensing or its own distribution arrangements for Maxigesic IV in eight of the top Pharma markets in the world: USA, Germany, France, Italy, UK (AFT Pharma UK Ltd), Canada (AFT Pharma Canada Ltd), Spain and now Brazil.